Humacyte, Inc. · NASDAQ:HUMA
Humacyte, Inc. shareholders
As of Sep 30, 2026, 126 institutions reported holding Humacyte, Inc., 19.6% of its shares. Largest: Vanguard, ANTIPODES PARTNERS Ltd and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Humacyte, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 13.4M | 4.8% | +1.54M | Nov 16, 2026 |
| ANTIPODES PARTNERS Ltd | 8.26M | 3.0% | −1.85M | Nov 4, 2026 |
| BlackRock | 4.57M | 1.6% | −274K | Nov 13, 2026 |
| Great Point Partners LLC | 3.75M | 1.3% | no change | Nov 16, 2026 |
| UBS | 3.01M | 1.1% | +164K | Nov 10, 2026 |
| Marshall Wace, LLP | 3M | 1.1% | +2.81M | Nov 13, 2026 |
| Geode Capital | 2.68M | 0.96% | +491K | Nov 6, 2026 |
| Citadel | 1.73M | 0.62% | +290K | Nov 16, 2026 |
| Susquehanna | 1.67M | 0.60% | −28,941 | Nov 16, 2026 |
| Schwab | 1.38M | 0.50% | +22,605 | Nov 16, 2026 |